The integration of molecular diagnostic methods into the clinical laboratory

Annals of Clinical and Laboratory Science

Volumn 29, Issue 1, 1999, Pages 43-54

  Mulcahy, Gabriel M ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DISEASE; BLOOD TRANSFUSION; CANCER DIAGNOSIS; CANCER GENETICS; CLINICAL CHEMISTRY; CLINICAL LABORATORY; CONTAMINATION; DIAGNOSTIC PROCEDURE; GENE MUTATION; GENETIC DISORDER; HLA TYPING; INFECTION; LABORATORY PERSONNEL; MICROBIOLOGY; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL;

GENETIC TECHNIQUES; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES;

EID: 0033063181     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Sunderman FW. Preparation and delivery or a speech in medicine and allied sciences. Ann Clin Lab Sci 1976;6:342-6.
2. Loeffelholz MJ, Lewinski CA, Silver SR, Purohit AP, Herman SA, Buonagurio DA, Dragon EA. Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. J Clin Microbiol 1992; 30:2847-51.
3. Bass CA, Jungkind DL, Silverman NS, Bondi JM. Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol 1993;31:2648-53.
4. Mahony JB, Luinstra KE, Sellors JW, Pickard L, Chong S, Jang D, Cherneskv MA. Role of confirmatory PCRs in determining performance of Chlamydia Amplicor PCR with endocervical specimens from women with a low prevalence of infection. J Clin Microbiol 1994;32:2490-3.
5. Mulcahy GM, Kaminski ZC, Albanese EA, Sood R, Pierce M. IS6110-based PCR methods for detection of Mycobacterium tuberculosis. J Clin Microbiol 1996; 34:1348-9 (letter).
6. Nolte FS, Metchock B, McGowan JE Jr, Edwards A, Okwumabua O, Thurmond C, Mitchell PS, Plikaytis B, Shinnick T. Direct detection of Mycobacterium tuberculosis in sputum by polymerase chain reaction and DNA hybridization. J Clin Microbiol 1993;31: 1777-82.
7. Moore DF, Curry JI. Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by Amplicor PCR. J Clin Microbiol 1995: 33:2686-91.
8. Tevere VJ, Hewitt PL, Dare A, Hocknell P, Keen A, Spadoro JP, Young KKY. Detection of Mycobacterium tuberculosis by PCR amplification with pan-Mycobacterium primers and hybridization to an M. tuberculosis-specific probe. J Clin Microbiol 1996;34: 918-23.
9. Wobeser WL, Krajden M, Conly J, Simpson H. Yim B, D'Costa M, Fuksa M, Hian-Cheong C, Patterson M, Phillips A, Bannatyne R, Haddad A, Brunton JL, Krajden S. Evaluation of Roche Amplicor PCR assay for Mycobacterium tuberculosis. J Clin Microbiol 1996;34:134-9.
10. Jackson KM, Edwards RM, Bowden DS, Leslie DE. Evaluation of the Roche Amplicor™ polymerase chain reaction system for detection of Mycobacterium tuberculosis complex in specimens. Pathology 1996; 28:65-7.
11. Bergmann JS, Woods GL. Clinical evaluation of the Roche AMPLICOR PCR Mycobacterium tuberculosis test for detection of M. tuberculosis in respiratory specimens. J Clin Microbiol 1996;34:1083-5.
12. Mahony JB, Jang D, Chong S, Luinstra K, Sellors J, Tyndall M, Chernesky M. Detection of Chlamydia trachomatis, Neisseria gonorrhoeae. Ureaplasma urealyticum, and Mycoplasma genitalium in first-void urine specimens by multiplex polymerase chain reaction. Mol Diagn 1997;2:161-8.
13. Kox LFF, Jansen HM, Kuijper S, Kolk AHJ. Multiplex PCR assay for immediate identification of the infecting species in patients with mycobacterial disease. J Clin Microbiol 1997;35:1492-8.
14. Post JC, White GJ, Aul JJ, Zavoral T, Wadowsky RM, Zhang Y, Preston RA, Ehrlich GD. Development and validation of a multiplex PCR-based assay for the upper respiratory tract bacterial pathogens Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. Mol Diagn 1996;1:29-39.
15. Williams DL, Spring L, Gillis TP, Sallinger M, Persing DH. Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens. Clin Infect Dis 1998;26:446-50.
16. Telenti A, Honoré N, Bernasconi C, March J, Ortega A, Heym B, Takiff HE, Cole ST. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997;35:719-23.
17. Salisbury SM, Sabatini LM, Spiegel CA. Identification of methicillin-resistant staphylococci by multiplex polymerase chain reaction assay. Am J Clin Pathol 1997;107:368-73.
18. Carroll KC, Leonard RB, Newcomb-Gayman PL, Hillyard DR. Rapid detection of the staphylococeal mecA gene from BACTEC blood culture bottles by the polymerase chain reaction. Am J Clin Pathol 1996; 106:600-5.
19. Mulder J, McKinney N, Christopherson C, Shinsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
20. Nolte FS, Boysza J, Thurmond C, Clark WS, Lennox JL. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1998;36: 716-20.
21. Coombs RW, HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS. Clin Lab Med 1994;14:301-11.
22. Simpson PR, Yu XH, Redza ZM, Anson JG, Chan SH, Lin Y. Quantification of hepatitis B virus DNA using competitive PCR and a scintillation proximity assay. J Virol Methods 1997;69:197-208.
23. Ferreira-Gonzalez A, Shiffman ML, Lofland DH, Langley MR, Gainey DW, Garrett CT. Assessing clinical utility of hepatitis C virus quantitative RT-PCR data: implications for identification of responders among α-interferon-treated patients. Mol Diagn 1996; 1:109-20.
24. Persing DH, Smith TF, Tenover FC, White TJ, editors. Diagnostic molecular microbiology: principles and applications. Washington: American Society for Microbiology, 1993.
25. Persing DH, editor. PCR protocols for emerging infections diseases. Washington: ASM Press, 1996.
26. Tang Y-W, Procop GW, Persing DH. Molecular diagnostics of infectious diseases. Clin Chem 1997;43: 2021-38.
27. Baselski VS. The role of molecular diagnostics in the clinical microbiology laboratory. Clin Lab Med 1996; 16:49-60.
28. Jonas V, Longiaru M. Detection of Mycobacterium tuberculosis by molecular methods. Clin Lab Med 1997;17:119-28.
29. Bray PF, Jin Y, Kickler T. Rapid genotyping of the live major platelet alloantigens by reverse dot-blot hybridization. Blood 1994;84:4361-7.
30. Marshall LR, Jones C, Munro TE. Prediction of neonatal alloimmune thrombocytopenia using PCR. Pathology 1994;26:46-7.
31. 11), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood 1997;89:2568-77.
32. Lee T-H, Donegan E, Slichter S, Busch MP. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood 1995;85:1207-14.
33. Bothwell TH, MacPhail AP. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin Hematol 1998;35:55-71.
34. Edwards CQ, Griffen LM, Ajioka RS, Kushner JP. Screening for hemochromatosis: phenotype versus genotype. Semin Hematol 1998;35:72-6.
35. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, Barton JC, Beutler E, Brittenham G, Buchanan A, Clayton EW, Cogswell ME, Meslin EM, Motulsky AG, Powell LW, Sigal E, Wilfond BS, Collins FS. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998;280:172-8.
36. Rezuke WN, Abernathy EC, Tsongalis GJ. Molecular diagnosis of B-and T-cell lymphomas: fundamental principles and clinical applications. Clin Chem 1997; 43:1814-23.
37. Rockman SP. Determination of clonality in patients who present with diagnostic dilemmas: a laboratory experience and review of the literature. Leukemia 1997;11:852-62.
38. Bunce M, Young NT, Welsh KI. Molecular HLA typing-the brave new world. Transplantation 1997;64: 1505-13.
39. Leushner J, Larsson P. Human lymphocyte antigen typing: direct DNA typing-the only choice? Mol Diagn 1997;2:287-98.
40. Perucho M. PCR and cancer diagnostics, detection and characterization of single point mutations in oncogenos and antioncogenes. In: Mullis KB, Ferré F, Gibbs RA, editors. The polymerase chain reaction. Boston: Birkhauser, 1994:369-94.
41. Ladanyi M. The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 1995;4:162-73.
42. Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 1996;78:10-6.
43. Hochhaus A, Reiter A, Skladny H, Reichert A, Sauβele S, Hehlmann R. Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy. Recent Results Cancer Res 1998;144:36-45.
44. van Dongen JJM, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992;6,suppl 1:47-59.
45. Alvarez M, Paull K, Monks A, Hose C, Lee J-S, Weinstein J, Grever M, Bates S, Fojo T. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Invest 1995; 95:2205-14.
46. Pall G, Spitaler M, Hofmann J, Thaler J, Ludescher C. Multidrug resistance in acute leukemia: a comparison of different diagnostic methods. Leukemia 1997;11: 1067-72.
47. Mulcahy GM, Goggins M, Willis D, Decker RA, Luce MC, Parsons R, Markowitz S, Narod SA, Holt JT, Page DL, Mauer AM, Thor A. Pathology and genetic testing. Cancer (suppl) 1997;80:636-48.
48. Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H, Kitamura Y. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 1998;19:323-4.
49. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons K. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-7.
50. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T, Koike M, Chiba M, Mori T. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997;17:271-2.
51. Schmidt L, Duh F-M, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJM, Walther MM, Tsui L-C, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997;16:68-73.
52. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S. Jeschke R, Muller O, Back W, Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998;18:38-43.
53. Lu S-L, Kawabata M, Imamura T, Akiyama Y, Nomizu T, Miyazono K, Yuasa Y. HNPCC associated with germline mutation in the TGF-β type II receptor gene. Nat Genet 1998;19:17-8.
54. Howe JR, Roth S, Ringold JC, Summers RW, Järvinen HJ, Sistonen P, Tomlinson IPM, Houlston RS, Bevan S, Mitros FA, Stone EM, Aaltonen LA. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998;280:1086-8.
55. th ed., 3 volumes. Baltimore: The Johns Hopkins University Press, 1998.
56. Bertina RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 1997;43:1678-83.
57. Sunderman FW Sr. Evolution of clinical science: an overview. Ann Clin Lab Sci 1993;23:231-18.
58. Belk WP, Sunderman FW. A survey of the accuracy of chemical analyses in clinical laboratories. Am J Clin Pathol 1947;17:853-61.
59. Sunderman FW Sr. The history of proficiency testing/ quality control. Clin Chem 1992;38:1205-9.
60. Narayanan S. Concepts, principles, and applications of selected molecular biology techniques in clinical biochemistry. Adv Clin Chem 1996;32:1-38.
61. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
62. Amplicor Chlamydia trachomatis package insert. Branchburg, NJ: Roche Diagnostic Systems, 1995.
63. Rys PN, Persing DH. Preventing false positives: quantitative evaluation of three protocols for inactivation of polymerase chain reaction amplification products. J Clin Microbiol 1993;31:2356-60.
64. Goodman JL, Bradley JF, Ross AE, Goellner P, Lagus A, Vitale B, Berger BW, Lager S, Johnson RC. Blood-stream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med 1995;99:6-12.
65. Priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis 1998;57:118-21.
66. Verkooyen RP, Luijendijk A, Huisman WM, Goessens WHF, Kluvtmans JAJW, van Rijsoort-Vos JH. Verbrugh HA. Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia tra-clmmatift assay. J Clin Microbiol 1996;34:3072-4.
67. Rosenstraus M, Wang Z, Chang S-Y, DeBonville D, Spadoro JP. An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J Clin Microbiol 1998;36:191-7.
68. Hadgu A. The discrepancy in discrepant analysis. Lancet 1996;348:592-3.
69. Hadgu A. Discrepant analysis and screening for Chlamydia trachomatis. Lancet 1996;348:1309 (author's reply).
70. Schachter J, Stamm WE, Quinn TC. Discrepant analysis and screening for Chlamydia trachomatis. Lancet 1996;348:1308-9 (letter).
71. Lynch HT, Fusaro RM, Lynch JF. Cancer genetics in the new era of molecular biology. Ann NY Acad Sci 1997;833:1-28.
72. Lynch HT, Lynch J. Genetic counseling for hereditary cancer. Oncology 1996;10:27-32,34.
73. Petersen GM, Codori A-M. Genetic testing for familial cancer. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill, 1998:591-9.
74. Garber JE, Schrag D. Testing for inherited cancer susceptibility. JAMA 1996;275:1928-9.
75. Peters JA, Biesecker BB. Genetic counseling and hereditary cancer. Cancer (suppl) 1997;80:576-86.
76. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 1996;14:1730-6.
77. Eisenberg RS. Structure and function in gene patenting. Nat Genet 1997;15:125-30.
78. Merz JF, Cho MK, Robertson MJ, Leonard DGB. Disease gene patenting is a bad innovation. Mol Diagn 1997;2:299-304.
79. Doll JJ. The patenting of DNA. Science 1998;280: 689-90.
80. Heller MA, Eisenberg RS. Can patents deter innovation? The anticommons in biomedical research. Science 1998;280:698-701.
81. DiDomenico N, Link H, Knobel R, Caratsch T, Weschler W, Loewy ZG, Rosenstraus M. COBAS AMPLICOR™: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR. Clin Chem 1996;42:1915-23.
82. Cheng J, Fortina P, Surrey S, Kricka LJ, Wilding P. Microchip-based devices for molecular diagnosis of genetic diseases. Mol Diagn 1996;1:183-200.
83. Kopp MU, de Mello AJ, Manz A. Chemical amplification: continuous-flow PCR on a chip. Science 1998: 280:1046-8.
84. Beattie KL, Beattie WG, Meng L, Turner SL, Coral-Vazquez R, Smith DD, McIntyre PM, Dao DD. Advances in genosensor research. Clin Chem 1995; 41:700-6.